Exagen

XGN · NASDAQ

$7.41−$0.02 (−0.27%)TodayMarket closed · Oct 20, 7:43 PM ET

Prev close $7.43

Latest news

NewsSep 17, 7:19 AM ET
Full Transcript: Exagen Q2 2026 Earnings Call
NewsAug 4, 1:05 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsAug 4, 8:05 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Press releaseAug 4, 8:00 AM ETGlobe Newswire
Exagen Inc. Reports Second Quarter 2026 Financial Results
Press releaseJun 1, 9:00 AM ETGlobe Newswire
Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus
NewsMay 11, 1:05 PM ET
12 Health Care Stocks Moving In Monday's Intraday Session
NewsMay 11, 8:06 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
Press releaseMay 11, 8:00 AM ETGlobe Newswire
Exagen Inc. Reports First Quarter 2026 Results
NewsMay 11, 7:11 AM ET
Earnings Scheduled For May 11, 2026
NewsMar 10, 4:00 PM ET
4 Analysts Have This To Say About Exagen
NewsMar 10, 8:04 AM ET
Exagen Earnings Report: Q4 Overview
Press releaseMar 10, 8:00 AM ETGlobe Newswire
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results
NewsMar 10, 7:11 AM ET
Earnings Scheduled For March 10, 2026
NewsMar 9, 1:03 PM ET
A Peek at Exagen's Future Earnings
Press releaseJan 11, 3:00 PM ETGlobe Newswire
Exagen Inc. Announces Select Preliminary 2025 Financial Results
Press releaseNov 4, 8:00 AM ETGlobe Newswire
Exagen Inc. Reports Strong Q3 2025 Results
Press releaseOct 23, 9:15 AM ETGlobe Newswire
Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence
NewsOct 22, 10:00 AM ET
Demystifying Exagen: Insights From 5 Analyst Reviews
NewsSep 11, 8:02 AM ET
Beyond The Numbers: 4 Analysts Discuss Exagen Stock
NewsJul 30, 8:00 AM ET
What Analysts Are Saying About Exagen Stock
NewsJul 29, 1:06 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
Press releaseJul 29, 8:00 AM ETGlobe Newswire
Exagen Inc. Reports Strong Q2 2025 Results
Press releaseJul 17, 4:05 PM ETGlobe Newswire
Exagen Inc. Appoints Chas McKhann to Board of Directors
Press releaseJun 23, 9:00 AM ETGlobe Newswire
Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics
NewsMay 8, 8:07 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsMay 7, 5:05 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Full Transcript: Exagen Q2 2026 Earnings Call

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Exagen Inc. Reports Second Quarter 2026 Financial Results

Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus

12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Monday's Pre-Market Session

Exagen Inc. Reports First Quarter 2026 Results

Earnings Scheduled For May 11, 2026

4 Analysts Have This To Say About Exagen

Exagen Earnings Report: Q4 Overview

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results

Earnings Scheduled For March 10, 2026

A Peek at Exagen's Future Earnings

Exagen Inc. Announces Select Preliminary 2025 Financial Results

Exagen Inc. Reports Strong Q3 2025 Results

Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence

Demystifying Exagen: Insights From 5 Analyst Reviews

Beyond The Numbers: 4 Analysts Discuss Exagen Stock

What Analysts Are Saying About Exagen Stock

12 Health Care Stocks Moving In Tuesday's Intraday Session

Exagen Inc. Reports Strong Q2 2025 Results

Exagen Inc. Appoints Chas McKhann to Board of Directors

Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics

12 Health Care Stocks Moving In Thursday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session